Expected observation 2: posts will offer services to consumers that facilitate access to GLP-1 medications from places perceived to be outside of traditional health care settings (eg, primary care, obesity medicine, endocrinology, or other specialty care). This evidence concerns the gene GLP1R and Obesity.